Market Synopsis
The demand for blood is relatively higher than its supply at present. This, in turn, is expected to increase the demand for blood transfusion diagnostics in the forthcoming years. As per the assessment offered by Market Research Future, the global blood transfusion diagnostics market is expected to mark a CAGR of 8.2% over the review period 2017 to 2023. The analysis also highlights that the market is poised to touch a valuation of USD 2.45 Bn by the end of the forecast period.
The rising cases of road accidents is a major factor expected to support the expansion of the blood transfusion diagnostics market in the nearby future. Every year millions are getting injured in road accidents which is anticipated to generate immense demand for blood transfusion diagnostics over the next couple of years.
The rising awareness created by the governments and organizations for promoting donations of blood is projected to expedite market expansion in the foreseeable future. Other factors such as blood bank automation, growth of the healthcare sector, development of advanced diagnostics, etc. are forecasted to catapult the blood transfusion diagnostics market on upward trajectory.
Get Free Sample Copy of “Blood Transfusion Diagnostics Market” @ https://www.marketresearchfuture.com/sample_request/1126
Competitive Dashboard
The prominent players participating in the share assessment of the Global Blood Transfusion Diagnostics Market are
- Thermo Fisher Scientific, Inc. (U.S.),
- Grifols (Spain),
- Roche Diagnostics (Switzerland),
- Bio-Rad Laboratories, Inc. (U.S.),
- BioMérieux (France),
- Immucor (U.SOrtho Clinical Diagnostics, Inc. (U.S.),
- Becton, Dickinson and Company (U.S.),
- Siemens Healthineers (Germany),
- Beckman Coulter, Inc. (U.S.),
- Novartis AG (Switzerland),
- Ortho Clinical Diagnostics (U.S),
- Diagast (France),
- Abbott Diagnostics (U.S),
- Beckman Coulter (U.S),
- BAG healthcare (Germany),
- Fujirebio (Belgium),
- DiaSorin (Italy),
- Grifols (Spain),
- Hologic/Gen-Probe (U.S),
- Quidel (U.S)
- Biokit (Spain)
Industry News
In January 2019, a leader in transfusion and transplantation diagnostics, Immucor, Inc., has announced that it has received approval from Health Canada for its next-gen fully automated Echo® instrument, Echo LumenaTM.
In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.
In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14th of the month.
Market Segmentation
The global blood transfusion diagnostics market, on the basis of blood product, has been segmented into platelets, red blood cells, plasma, immunoglobulin preparations, albumin, and other products.
Based on technology, the blood transfusion diagnostics market has been segmented into ELISA, nucleic acid amplification, rapid test, western blot, fluorescence assay, and others. The ELISA segment has been sub-segmented into fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The nucleic acid amplification segment is sub-divided into Thermomechanical analysis (TMA) and real-time PCR.
By end-users, the global blood transfusion diagnostics market has been segmented into clinics, blood banks, hospitals, laboratories.
Get More Professional and Technical Industry Insights @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
Regional Assessment
The global blood transfusion diagnostics market, on the basis of region, has been segmented into four key regions, viz. Europe, Asia Pacific, Americas, and the Middle East and Africa (MEA). Americas is prognosticated to account for the maximum market share in the forthcoming years. The growth can be ascribed to the rising adoption of nucleic acid amplification test. In addition, the increasing count of road accidents is also poised to favor market growth in the region. Europe is in the second spot and is likely to grow significantly over the next couple of years. The rising awareness about blood donation and investments in blood donation campaigns are anticipated to boost revenue generation for the market players. Asia Pacific is also prognosticated to exhibit rapid developments. The exponential population growth of the region is likely to benefit the growth pattern of the blood transfusion diagnostics market.